Zobrazeno 1 - 10
of 64
pro vyhledávání: '"T K Daneshmend"'
Autor:
T K, Daneshmend, J D, Davies
Publikováno v:
Bristol Medico-Chirurgical Journal
We report a case of phenytoin-associated Hodgkin's disease of lymphocyte predominance subtype, which developed after two years of phenytoin (Epanutin) treatment. Four other English cases of phenytoin-associated lmphoid malignancy are also reviewed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::deb75b1b0ab400140f6a257e7c93212d
https://pubmed.ncbi.nlm.nih.gov/28906754
https://pubmed.ncbi.nlm.nih.gov/28906754
Autor:
T. K. Daneshmend, R. G. Long, M. Collins, R. P. Walt, Christopher J. Hawkey, B. T. Cooper, Michael J.S. Langman, R. F. A. Logan, R. Street
Publikováno v:
Alimentary Pharmacology & Therapeutics. 5:301-307
SUMMARY Roxatidine acetate is a new histamine H2-antagonist of about twice the potency of ranitidine on a weight-for-weight basis. Two hundred and thirty-two patients participated in a double-blind randomized trial of duodenal ulcer healing comparing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb99bf9df34d994b59d20169251d9709
https://doi.org/10.1111/j.1365-2036.1991.tb00031.x
https://doi.org/10.1111/j.1365-2036.1991.tb00031.x
Autor:
T. K. Daneshmend, C. Malkinson, S. J. Everitt, A. B. Hawthorne, Andrea Belluzzi, M. Z. Shaheen, G. K. T. Holmes, Christopher J. Hawkey, J. E. Willars
Publikováno v:
Gut. 33:922-928
The effect of fish oil on the course of ulcerative colitis was investigated in a randomised blinded controlled study. Eighty seven patients received supplements of 20 ml HiEPA fish oil as triglyceride (4.5 g of eicosapentaenoic acid) or olive oil pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66984cfe92a7c639fb42d07d23ca50eb
https://doi.org/10.1136/gut.33.7.922
https://doi.org/10.1136/gut.33.7.922
Autor:
Michael J.S. Langman, Christopher J. Hawkey, T. K. Daneshmend, R. P. Walt, R. F. A. Logan, R. G. Long
Publikováno v:
BMJ. 304:143-147
OBJECTIVE--To investigate the possible therapeutic role of omeprazole, a powerful proton pump inhibitor, in unselected patients presenting with upper gastrointestinal bleeding. DESIGN--Double blind placebo controlled parallel group study. Active trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2563223c7eb4943b8a2756e8dafea88
https://doi.org/10.1136/bmj.304.6820.143
https://doi.org/10.1136/bmj.304.6820.143
Autor:
Christopher J. Hawkey, A. B. Hawthorne, N. Hudson, A. T. Cole, Yashwant R. Mahida, T. K. Daneshmend
Publikováno v:
Clinical Science. 81:565-573
1. An increasing body of data suggests that the anti-haemostatic as well as the ulcerogenic actions of aspirin and other non-steroidal anti-inflammatory drugs may be operative when patients present with haematemesis and melaena. 2. We therefore devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9415d5d5e1049bf90073082e6672f85d
https://doi.org/10.1042/cs0810565
https://doi.org/10.1042/cs0810565
Publikováno v:
BMJ. 300:986-990
OBJECTIVE--To evaluate the medical impact of reactive pharmacy intervention. DESIGN--Analysis of all interventions during 28 days by all 35 pharmacists in hospitals in Nottingham. SETTING--All (six) hospitals in the Nottingham health authority (a tea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bfa50086f697cc2b3d845c38abdf401
https://doi.org/10.1136/bmj.300.6730.986
https://doi.org/10.1136/bmj.300.6730.986
Publikováno v:
Gut. 62:A73.2-A74
Introduction Recent meta-analyses of population based IBD mortality studies have shown no increase in standardised mortality ratio for ulcerative colitis (UC) 1 , but a small increase for Crohn’s disease (CD) 2 . 26–50% of deaths in CD patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63aaca37269b17414629d6e8933866a4
https://doi.org/10.1136/gutjnl-2013-304907.163
https://doi.org/10.1136/gutjnl-2013-304907.163
Autor:
K So, C Bewshea, G A Heap, A F Muller, T K Daneshmend, A L Hart, T R Orchard, P M Irving, R K Russell, D C Wilson, M Parkes, J Satsangi, C W Lees, T Ahmad
Publikováno v:
Gut. 62:A22.1-A22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59ba6fbcc0c4a0c26f51144507b98943
https://doi.org/10.1136/gutjnl-2013-304907.049
https://doi.org/10.1136/gutjnl-2013-304907.049
OBJECTIVE--To assess the cost effectiveness of screening for and eradicating Helicobacter pylori in patients under 45 years of age presenting with dyspepsia. DESIGN--A decision analytic model composed of a decision tree to represent the epidemiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f54bfe4f88a66252b266fb4de49e7df3
https://europepmc.org/articles/PMC2352015/
https://europepmc.org/articles/PMC2352015/
Publikováno v:
Gut. 60:A215-A215
Introduction Infliximab (IFX) has been shown to be efficacious in the treatment of steroid refractory acute severe ulcerative colitis (ASUC) with reduced rates of colectomy at index admission and at 3-year follow-up. Previous studies from tertiary re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04594ad0ab9d2302f52b60f96bb67630
https://doi.org/10.1136/gut.2011.239301.454
https://doi.org/10.1136/gut.2011.239301.454